Strategies for gene cloning

Urological Research

Volumn 27, Issue 2, 1999, Pages 83-96

  Schamhart, Denis H J ^a   Westerhof, Alex C C ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Diagnostics; DNA chip technology; Gene cloning; Gene therapy; Genitourinary malignancies; Recombinant DNA

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; RECOMBINANT DNA;

ESCHERICHIA COLI; FLUORESCENCE IN SITU HYBRIDIZATION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSCRIPTION; MOLECULAR CLONING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; RECOMBINANT DNA TECHNOLOGY; REVIEW; TRANSCRIPTION REGULATION; UROGENITAL TRACT CANCER;

ANIMALS; CHROMOSOME ABERRATIONS; CLONING, MOLECULAR; DNA RESTRICTION ENZYMES; DNA, RECOMBINANT; FORECASTING; GENE THERAPY; GENETIC VECTORS; HUMANS; TRANSCRIPTION, GENETIC; UROGENITAL NEOPLASMS;

EID: 0032935159     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002400050093     Document Type: Review

References (83)

1. Arber W (1979) Promotion and limitation of genetic exchange. Science 205:361
2. Aruffo A, Seed B (1987) Molecular cloning of a CD28 cDNA by a high-efficiency cos cell expression system. Proc Natl Sci USA 84:8573
3. Bates PF, Swift RA (1983) Double cos site vectors: simplified cosmid cloning. Gene 26:137
4. Bell J (1989) The polymerase chain reaction. Immunol Today 10:351
5. Berg P (1981) Dissection and reconstruction of genes and chromosomes. Science 213:296
6. Brewster SF, Simons JW (1994) Gene therapy in urological oncology: principles, strategies and potential. Eur Urol 25:177
7. Burke DT, Carle GF, Olson MV (1987) Cloning of large segments of exogenous DNA into yeast by means of artificial chromosome vectors. Science 236:806
8. Bussemakers MJG, Van de Ven WJM, Debruyne FMJ, Schalken JA (1991) Identification of high mobility group protein I(Y) as potential progression marker for prostate cancer by differential hybridization analysis. Cancer Res 51:606
9. Carroll WL (1993) Introduction to recombinant-DNA technology. Am J Clin Nutr 58(Suppl):249 S
10. Cleutjens KB, Eekelen CC van, Korput HA van der, Brinkmann AO, Trapman J (1996) Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter. J Biol Chem 271:6379
11. Cordon-Cardo C, Sheinfeld J, Dalbagni G (1997) Genetic studies and molecular markers of bladder cancer. Semin Surg Oncol 13:319
12. Cremer T, Landegent J, Brueckner A, Scholl HP, Schardin M, Hager HD, Devilee P, Pearson P, Ploeg M van der (1986) Detection of chromosome aberrations in the human interphase nucleus by visualization of specific target DNAs with radioactive and non-radioactive in situ hybridization techniques: diagnosis of trisomy 18 with probe L1.84. Hum Genet 74:346
13. Cremer T, Lichter P, Borden J, Ward DC, Manuelidis L (1988) Detection of chromosome aberrations in metaphase and interphase tumor cells by in situ hybridization using chromosome-specific library probes. Hum Genet 80:235
14. Davis BM, Koc ON, Lee K, Gerson SL (1996) Current progress in the gene therapy of cancer. Curr Opin Oncol 8:499
15. Dong J-T, Isaacs WB, JT (1997) Molecular advances in prostate cancer. Curr Opin Oncol 9:101
16. Du Manoir S, Speicher MR, Joos S, Schrock E, Popp S, Dohner H, Kovacs G, Robert-Nicoud M, Lichter P, Cremer T (1993) Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet 90:590
17. Eastham JA, Chen SH, Sehgal I, Yang G, Timme TL, Hall SJ, Woo SL, Thompson TC (1996) Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models. Hum Gene Ther 7:515
18. Elshami AA, Saavedra A, Zhang H, Kucharczuk JC, Spray DC, Fishman GI, Amin KM, Kaiser LR, Albelda SM (1996) Gap junctions play a role in the "bystander effect" of the herpes simplex virus thymidine kinase/ganciclovir system in vitro. Gene Ther 3:85
19. Eschwège P, Dumas F, Blanchet P, Le Maire V, Benoit G, Jardin A, Lacour B, Loric S (1995) Haematogenous dissemination of prostatic epithelial cells during radical prostatectomy. Lancet 346:1528
20. Falk R (1984) The gene in search of an identity. Hum Genet 68:195
21. Florijn RJ, Bonden LA, Vrolijk H, Wiegant J, Vaandrager JW, Baas F, den Dunnen JT, Tanke HJ, van Ommen GJ, Raap AK (1995) High-resolution DNA fiber-FISH for genomic DNA mapping and colour bar-coding of large genes. Hum Mol Genet 4:831
22. Frieman T (1997) Overcoming the obstacles to gene therapy. Sci Am 276:80
23. Gelb AB (1997) Renal cell carcinoma: current prognostic factors. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80:981
24. Hacia JG, Brody LC, Chee MS, Fodor SPA, Collins FS (1996) Detection of heterozygous mutations in BRCAI using high density oligonucleotide array and two-color fluorescent analysis. Nat Genet 14:441
25. Hall SJ, Mutchnik SE, Chen SH, Woo SL, Thompson TC (1997) Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer. Int J Cancer 70:183
26. Hakvoort TBM, Leegwater ACJ, Michiels FAM, Chamuleau RAFM, Lamers WH (1994) Identification of enriched sequences from a cDNA subtraction-hybridization procedure. Nucleic Acids Res 22:878
27. Harris JD, Gutierrez AA, Hurst HC, Sikora K, Lemoine NR (1994) Gene therapy for cancer using tumor-specific prodrug activation. Gene Ther 1:170
28. Isaacs JT (1997) Molecular markers for prostate cancer metastasis. Developing diagnostic methods for predicting the aggressiveness of prostate cancer. Am J Pathol 150:1511
29. John H, Birnstiel ML, Jones KW (1969) RNA-DNA hybridization at cytological levels. Nature 223:582
30. Johnson KR, Lehn DA, Elton TS, Barr PJ, Reeves R (1988) Complete murine cDNA sequence, genomic structure, and tissue expression of the high mobility group protein HMG-I(Y). J Biol Chem 263:18338
31. Kallioniemi O-P, Kallioniemi A, Studar D, Rutovitz D, Gray JW, Waldman F, Pinkel D (1993) Comparative genomic hybridization: a rapid new method for detection and mapping DNA amplification in tumors. Semin Cancer Biol 4:41
32. Kawakita M, Rao GS, Ritchey JK, Ornstein DK, Hudson M'SA, Tartaglia J, Paoletti E. Humphrey PA, Harmon TJ, Ratliff TL (1997) Effect of canarypox virus (ALVAC)-mediated cytokine expression on murine prostate tumor growth. J Natl Cancer Inst 89:428
33. Kimmel AR, Berger SL (1987) Preparation of cDNA and the generation of cDNA libraries: overview. Methods Enzymol 152:307
34. nd edn. W.H. Freeman, New York
35. Kovacs G (1996) Molecular genetics of human renal cell tumours. Nephrol Dialysis Transp 11(Suppl 6):62
36. Leder P, Clayton DA, Rubenstein E (eds) (1994) Introduction to molecular medicine. Scientific American, New York
37. Liebert M, Seigne J (1996) Characteristics of invasive bladder cancers: histological and molecular markers. Semin Urol Oncol 14:62
38. Lundwall C (1989) Characterization of the gene for prostate-specific antigen, a human glandular kallikrein. Biochem Biophys Res Commun 161:1151
39. Lundwall C, Lilja H (1987) Molecular cloning of human prostate specific antigen DNA. FEBS Lett 214:317
40. Meloni AM, Peier AM, Haddad FS, Powell IJ, Block AW, Huben RP, Todd I, Potter W, Sandberg AA (1993) A new approach in the diagnosis and follow-up of bladder cancer. FISH analysis of urine, bladder washings, and tumors. Cancer Gen Cytogen 71:105
41. Mickisch GH, Aksentijevich I, Schoenlein PV, Goldstein LJ, Galski H, Stahle C, Sachs DH, Pastan I, Gottesman MM (1992) Transplantation of bone marrow cells from transgenic mice expressing the human MDR1 gene results in long-term protection against the myelosuppressive effect of chemotherapy in mice. Blood 79:1087
42. Mickisch GH, Schroeder FH (1994) From laboratory expertise to clinical practice: multidrug-resistance-based gene therapy becomes available for urologists. World J Urol 12:104
43. Mulligan RC, Berg P (1980) Expression of a bacterial gene in mammalian cells. Science 209:1422
44. Mullis KB, Faloona F (1987) Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol 155:335
45. Murray NE (1983) The bacteriophage lambda, Vol 2. Cold Spring Harbor Laboratory, New York
46. Netto GJ, Humphrey PA (1994) Molecular biological aspects of human prostatic carcinoma. Am J Clin Pathol 102 (Suppl 1):S57
47. Old RW, Primrose SB (1985) Principles of gene manipulation. Blackwell Scientific Publications, Oxford
48. Olson MV (1994) The human genome project. In: Leder P, Clayton DA, Rubenstein E (eds) Introduction to molecular medicine. Scientific American, New York, p 133
49. Pandha HS, Sikora K (1995) Gene therapy for urological cancer. Br J Urol 75 (Suppl. 1):67
50. Pang S, Taneja S, Dardashti K, Cohan P, Kaboo R, Sokoloff M, Tso CL, Dekernion JB, Belldegrun AS (1995) Prostatic tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancer. Hum Gene Ther 6:1417
51. Pardue ML, Gall JG (1969) Molecular hybridization of radioactive DNA to the DNA of cytological preparations. Proc Natl Acad Sci USA 64:600
52. Riegman PHJ, Klaassen P, van der Korput JAGM, Romijn JC, Trapman J (1988) Molecular cloning and characterization of novel prostate antigen cDNAs. Biochem Biophys Res Comm 155:181
53. Roth JA, Cristiano RJ (1997) Gene therapy for cancer: what have we done and where are we going? J Natl Cancer Inst 89:21
54. Roy-Burman P, Zheng J, Miller GJ (1997) Molecular heterogeneity in prostate cancer: can TP53 mutation unravel tumorigenesis? Mol Med Today 3:476
55. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA (1988) Primer directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487
56. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N (1985) Enzymatic amplification of beta-globulin genomic sequence and restriction site analysis for diagnosis of sickle cell anemia. Science 230:1350
57. Sanger F, Coulson AR, Barrell BG, Smith AJH, Roe BA (1980) Cloning in single stranded bacteriophage as an aid to rapid DNA sequencing. J Mol Biol 143:161
58. Sauter G, Moch H, Carroll P, Kerschmann R, Mihatsch MJ, Waldman FM (1995) Chromosome-9 loss detected by fluorescence in situ hybridization in bladder cancer. Int J Cancer 64:99
59. Savill J (1997) Science, medicine, and the future. Prospecting for gold in the human genome. Br J Med 314:43
60. Sawicki MP, Samara G, Hurwitz M, Passaro E Jr (1993) Human Genome Project. Am J Surg 165:258
61. Schamhart DHJ, Kurth KH (1994) Glycosaminoglycans and prostate cancer: a therapeutic future? Perfusion 7:1
62. Schamhart DHJ, Kurth KH (1997) Role of proteoglycans in cell adhesion of prostate cancer cells: from review to experiment. Urol Res 25 (Suppl 2):S89
63. Schedlich LJ, Bennets BH, Morris BJ (1987) Primary structure of a human glandular kallikrein gene. DNA 6:429
64. Shoham Z, Insler V (1996) Recombinant technique and gonadotropins production: new era in reproductive medicine. Fertil Steril 66:187
65. Sikora K, Pandha HS (1997) Gene therapy for prostate cancer. Br J Urol 75 (Suppl 2):64
66. Simons JW, Marshall FF (1998) The future of gene therapy in the treatment of urologie malignancies. Urol Clin North Am 25:23
67. Simons JW, Jaffee EM, Weber CE, Levitsky HI, Nelson WG, Carducci MA, Lazenby AJ, Cohen LK, Finn CC, Clift SM, Hauda KM, Beck LA, Leiferman KM, Owens AH Jr, Piantadosi S, Dranoff G, Mulligan RC, Pardoll DM, Marshall FF (1997) Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer. Cancer Res 57:1537
68. Simpson AJG, Walker T, Terry R (1986) An introduction to recombinant DNA technology. Parasitology 91:S7
69. Singer M, Berg P (1991) Genes and genomes. University Science Books, Mill Valley
70. Tamimi Y, van der Poel HG, Denyn M-M, Umbas R, Karthau HFM, Debruyne FMJ, Schalken JA (1993) Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization. Cancer Res 53:5512
71. Verkaik NS, Schröder FH, Romijn JC (1997) Clinical usefulness of RT-PCR detection of hematogenous prostate cancel-spread. Urol Res 25:373
72. Vieira J, Messing J (1982) The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers. Gene 19:259
73. Vieira J, Messing J (1987) Production of single-stranded plasmid DNA. Methods Enzymol 153:3
74. Wallace RW (1997) DNA on a chip: serving up the genome for diagnostics and research. Mol Med Today 3:384
75. Watson JD, Crick FH (1953) Molecular structure of nucleic acids: a structure for deoxyribose nucleic acid. Nature 171:737
76. Watson JD, Crick FH (1953) Genetic implications of the structure of deoxyribose nucleic acid. Nature 171:964
77. Watson JD, Crick FHC (1953) The structure of DNA. Cold Spring Harbor Symp Quant Biol 18:123
78. nd edn. W. H. Freeman, New York
79. th edn. Benjamin/Cummings, Menlo Park
80. Wilhelm M, Krause U, Kovacs G (1995) Diagnosis and prognosis of renal-cell tumors: a molecular approach. World J Urol 13:143
81. Wygoda MR, Wilson MR, Davis MA, Trosky JE, Rehemtulla A, Lawrence TS (1997) Protection of herpes simplex virus thymidine kinase-transducted cells from ganciclovir-mediated cytotoxicity by bystander cells: the Good Samaritan effect. Cancer Res 57:1699
82. Young CYF, Andrews PE, Montgomery BT, Tindall DJ (1992) Tissue-specific and hormonal regulation of human prostate-specific glandular kallikrein. Biochem 31:818
83. Zhang J, Russell SJ (1996) Vectors for cancer gene therapy. Cancer Metastasis Rev 15:385